Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Accolade, Inc. (ACCD : NSDQ)
 
 • Company Description   
Accolade Inc. provides personalized, technology-enabled solutions which help people better understand, navigate and utilize the healthcare system. Accolade Inc. is based in SEATTLE.

Number of Employees: 2,350

 
 • Price / Volume Information   
Yesterday's Closing Price: $11.95 Daily Weekly Monthly
20 Day Moving Average: 589,642 shares
Shares Outstanding: 72.79 (millions)
Market Capitalization: $869.80 (millions)
Beta: 1.62
52 Week High: $19.39
52 Week Low: $4.61
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.10% 4.36%
12 Week 43.11% 39.25%
Year To Date 53.40% 49.05%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
660 W. Germantown Pike Suite 500
-
Plymouth Meeting,PA 19462
USA
ph: 206-926-8100
fax: -
ir@accolade.com http://www.accolade.com
 
 • General Corporate Information   
Officers
Rajeev Singh - Chief Executive Officer and Chairman
Stephen Barnes - Chief Financial Officer
Jeff Brodsky - Director
Jeffrey Jordan - Director
Cindy Kent - Director

Peer Information
Accolade, Inc. (EVOL)
Accolade, Inc. (RAMP)
Accolade, Inc. (ALOT)
Accolade, Inc. (TGHI)
Accolade, Inc. (GNCMA)
Accolade, Inc. (GSIC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: 00437E102
SIC: 7389
Fiscal Year
Fiscal Year End: February
Last Reported Quarter: 11/01/22
Next Expected EPS Date: 04/27/23
Share - Related Items
Shares Outstanding: 72.79
Most Recent Split Date: (:1)
Beta: 1.62
Market Capitalization: $869.80 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.56 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.07 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 9.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 7.16% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 04/27/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.77
Price/Cash Flow: -
Price / Sales: 2.43
EPS Growth
vs. Year Ago Period: 13.85%
vs. Previous Quarter: 15.15%
Sales Growth
vs. Year Ago Period: 8.98%
vs. Previous Quarter: 3.77%
ROE
02/28/23 - -
11/30/22 - -28.47
08/31/22 - -26.12
ROA
02/28/23 - -
11/30/22 - -16.65
08/31/22 - -15.85
Current Ratio
02/28/23 - -
11/30/22 - 3.14
08/31/22 - 3.33
Quick Ratio
02/28/23 - -
11/30/22 - 3.14
08/31/22 - 3.33
Operating Margin
02/28/23 - -
11/30/22 - -47.39
08/31/22 - -50.04
Net Margin
02/28/23 - -
11/30/22 - -129.59
08/31/22 - -114.56
Pre-Tax Margin
02/28/23 - -
11/30/22 - -129.51
08/31/22 - -113.55
Book Value
02/28/23 - -
11/30/22 - 6.76
08/31/22 - 7.11
Inventory Turnover
02/28/23 - -
11/30/22 - -
08/31/22 - -
Debt-to-Equity
02/28/23 - -
11/30/22 - 0.58
08/31/22 - 0.56
Debt-to-Capital
02/28/23 - -
11/30/22 - 36.71
08/31/22 - 35.73
 

Powered by Zacks Investment Research ©